pharmaphorum

APRIL 20, 2021

NICE’s final appraisal document for Kesimpta will be followed by technology appraisal guidance (TAG) that will pave the way for NHS prescribing in England and Wales. Analyst Philippa Salter of GlobalData recently predicted that Kesimpta’s convenience will make it a sought-after option for RMS patients, driving global sales to $3.3

Sales 110

Sales Medicine Drugs Marketing 110

Pharmaceutical Technology

FEBRUARY 22, 2023

Both drugs come with a high price tag. Since April 2020, Sanofi is responsible for Praluent outside of the US, while Regeneron handles its sale in the US. Since April 2020, Sanofi is responsible for Praluent outside of the US, while Regeneron handles its sale in the US. Amgen’s Repatha was greenlit a month later.

Antibody 262

Antibody Drugs Sales Protein 262

pharmaphorum

AUGUST 21, 2022

Auvelity isn’t the first NMDA-targeting antidepressant to reach the market. The biotech hasn’t revealed much information about the reasons for the delay in getting approval, but said in an SEC filing in June this year that it had agreed to “post-marketing commitments” proposed by the FDA, without going into details.

Drugs 98

Drugs FDA Approval Production Marketing 98

World of DTC Marketing

JUNE 23, 2021

sales alone, which is above consensus estimates of around $7 billion to $8 billion, the team said. In my career in healthcare marketing, I have done my best to understand the “science” behind certain health conditions along with how some medications can help. history.” government.

Drugs 218

Drugs FDA Approval Doctors Doctor 218

pharmaphorum

MARCH 23, 2022

Vyvgart (efgartigimod alfa) became the first drug in the FcRn class to be approved by the FDA last December, and despite a $225,000 annual price tag is predicted to make relatively modest sales in its IV version, which will compete with other IV gMG drugs like AstraZeneca/Alexion’s C5 inhibitor Soliris (eculizumab).

Antibody 52

Antibody Sales FDA Approval Trials 52

XTalks

OCTOBER 19, 2023

In fact, Rao’s accounted for nearly 70 percent of Sovos Brands’ 2022 sales , or $837 million. Despite the premium price tag, the brand has gained a cult following thanks to its inclusion of high quality ingredients and successful word-of-mouth marketing. Sovos, which was only founded six years ago, went public in 2021.

Branding 59

Branding Packaging Packaging Production 59

pharmaphorum

DECEMBER 17, 2021

Aduhelm (aducanumab) was approved by the FDA in June, but has been held back by a glacial rollout as clinicians have questioned the data on which the decision to clear the drug was based, plus a $56,000 per year price tag, which has in turn led to pushback by payers.

Trials 52

Trials Sales Marketing FDA Approval 52

pharmaphorum

JUNE 2, 2022

Evaluate Pharma’s recent Orphan Drug Report subtitled its overview of the market ‘Niche no longer.’ This is based on the relative success orphan drugs have achieved, in terms of the number of approvals and the sales figures achieved for this area. It is estimated that between 3.5 of the global population are affected by a rare disease.

Drugs 52

Drugs Sales Marketing Development 52

XTalks

AUGUST 25, 2021

In-store food sampling is a key marketing tactic that virtually disappeared during the height of the COVID-19 pandemic. Pre-pandemic, Daniel Maloney could be found working sample booths at food markets around New York City, telling consumers about the brand’s rich history and commitment to ethical farming.

Branding 98

Branding Marketing Nurses Production 98

pharmaphorum

NOVEMBER 24, 2022

Johnson & Johnson’s Spravato therapy for treatment-resistant depression (TRD) hasn’t made the impact the company hoped for in the market, and it is looking to new clinical results to accelerate its take-up. and 17.6%, respectively, according to J&J’s pharma unit Janssen. and 14.1%, respectively.

Trials 52

Trials Sales Drugs Marketing 52

Intouch Solutions

APRIL 11, 2024

Precision engagement is a data-driven approach developed for marketing and sales needs. The pharmaceutical industry is no stranger to innovation. It has continually evolved, embracing new technologies and methodologies to improve drug discovery, development, and distribution.

Compliance 52

Compliance Marketing Drugs Pharma Companies 52

pharmaphorum

DECEMBER 2, 2020

Here we take a look at the colourful history of one of the biggest drugmakers in the world. Pfizer was founded in 1849 by two recent German immigrants to the USA, Charles Pfizer and Charles Erhart. It was a success, and set the pattern for the company’s future development. Pfizer’s Tokyo building.

Sales 128

Sales Production Drugs Marketing 128

pharmaphorum

MAY 17, 2021

C5 inhibitor Soliris – which has a list price in the US of more than $500,000 per year – has been a standard therapy for the rare disorder since 2007, and was joined on the market by longer-acting follow-up Ultomiris in 2018 which launched with a price tag of around $450,000 per year. billion and $1.1

Drugs 52

Drugs FDA Approval Marketing Clinical Trials 52

pharmaphorum

JUNE 8, 2021

Instead, the FDA granted Aduhelm a conditional approval, allowing it to be prescribed and used while Biogen conducts a post-marketing, phase 4 confirmatory study – which could take years to complete. If benefit is not verified, we can act to remove the drug from the market. Broad label questioned.

Drugs 98

Drugs Marketing FDA Approval Trials 98

The Pharma Data

MARCH 16, 2022

using SNAP-tag) involves labeling cell proteins with a fluorescent dye, thereby enabling researchers to observe how proteins interact in the living cell and where in the cell they are located. With Spirochrome, he commercialized fluorescent probes for cell biology, while with Covalys, he marketed SNAP-tag and other protein labeling methods.

Protein 52

Protein Scientist Gene Development 52

Pharmacy Checkers

FEBRUARY 21, 2020

While that ban was put in place to stop companies from reimporting and selling American-made drugs in the commercial market, it can stop patients from reimporting a drug they bought in a foreign country for their own use. I published the comments in their entirety on Prescription Justice here: [link]. Emphasis added.

Drugs 61

Drugs FDA Approval Manufacturing Pharmacy 61

XTalks

MARCH 22, 2023

To celebrate this milestone, we’re taking a look back over the last 20 years in the pharmaceutical industry by highlighting some of the most talked-about mergers, blockbuster drugs, trends in FDA approvals and what’s next. And make sure you’re registered for our free online community for instant access to thousands of on-demand webinars.

Life Science 97

Life Science Drugs FDA Approval Vaccination 97

pharmaphorum

MAY 24, 2021

Modular content is an established practice among digital and content marketers in sectors such as FMCG and retail, who are challenged with increasing demand for more content and creating personalised content to meet the demands of their customers. Robb DeFilippis. Doing more in the digital space.

Marketing 99

Marketing Branding Sales Life Science 99

Pharmaceutical Technology

JUNE 21, 2023

The high price tag may be hard to defend , but with lifetime treatment costs for haemophilia B reaching as high as $23m for some, the single-dose treatment could prove far more cost-effective. UniQure announced that it had received $100m from this first commercial sale milestone, on top of a $450m upfront payment.

Gene Therapy 246

Gene Therapy Gene Sales Protein 246

pharmaphorum

NOVEMBER 19, 2021

The race to find and bring vaccines to market to fight Covid was impressive. So too are the sales figures. Pfizer/BioNTech’s vaccine dominates the market. billion in vaccine sales this year. Together, these mRNA jabs have an iron grip on the covid vaccine market – in the US, they have consolidated a 90% market share.

Sales 137

Sales Vaccination Vaccine Marketing 137

XTalks

APRIL 6, 2021

Where flour, pasta and other shelf-stable goods once sat in abundance quickly emptied to nothing but price tags. Most grocery shoppers won’t soon forget the perplexing moment last spring when shelves were suddenly bare. The same went for meat and dairy. It was a shocking, yet humbling, sight for most.

Production 104

Production Sales Vaccination Vaccine 104

Drug Discovery World

NOVEMBER 13, 2023

Ahead of protein and antibody engineering conference PEGS Europe 2024 in Lisbon, DDW’s Megan Thomas looks at what to expect from each track of the annual biologics technology meeting. Ali Madani, PhD, Founder and CEO, Profluent Bio, on: ‘Protein engineering with large language models’.

Protein 59

Protein Antibody Engineer Scientist 59

Cloudbyz

JUNE 1, 2023

For example, you can set up a rule to change the lead status to “working” once the sales representative has made the first contact. For instance, if a new lead from a certain region comes in, the task of contacting that lead can be automatically assigned to the sales rep responsible for that region.

Compliance 87

Compliance Development Branding Production 87

The Pharma Data

MAY 4, 2021

Raises Full-Year 2021 Guidance (3) for Revenues to a Range of $70.5 Billion and Adjusted Diluted EPS (2) to a Range of $3.55 Now Anticipates Revenues of Approximately $26 Billion for BNT162b2, Reflecting 1.6 Billion Doses Expected to be Delivered in 2021 Under Signed Contracts as of Mid-April 2021. Viatris) (4). EXECUTIVE COMMENTARY.

Vaccination 40

Vaccination Vaccine Production Sales 40

Pharma Marketing Network

OCTOBER 4, 2020

Don ( PMN): Hello everyone thanks for joining us at the Pharma marketing podcast. He’s a serial entrepreneur, a search engine marketing evangelist and a passionate networker. I’m your host Don Langsdorf our guest today is Vlad Mkrtumyan. Vlad (LI): Great that you want to kick it off.

Doctors 52

Doctors Doctor Marketing Packaging 52

Drug Discovery World

NOVEMBER 9, 2023

Ahead of protein and antibody engineering conference PEGS Europe 2024 in Lisbon, DDW’s Megan Thomas looks at what to expect from each track of the annual biologics technology meeting. Kielczewska will present: ‘Discovery of antibody-based therapeutics to challenging targets: Platform considerations’.

Engineer 52

Engineer Antibody Protein In-Vivo 52

pharmaphorum

AUGUST 26, 2022

The US biotech claimed conditional marketing approval from the European Commission for Roctavian (valoctocogene roxaparvovec) as a treatment for adults with severe haemophilia A, who don’t have a history of developing the antibodies that inhibit the activity of blood-clotting protein Factor VIII. million spread over five years.

Gene Therapy 110

Gene Therapy Gene Antibody Marketing 110

pharmaphorum

MARCH 27, 2022

The decision comes less than a month after Carvykti was approved by the FDA as a fifth-line therapy for multiple myeloma, teeing up a tussle in the market with Bristol-Myers Squibb and bluebird bio spinout 2seventy’s Abecma (idecabtagene autoleucel) which was approved for a similar indication last year.

Antibody 97

Antibody Clinical Trials Clinical Trials Sales 97

The Pharma Data

MAY 15, 2021

If within the first 60 days of receipt you are not satisfied with Wake Up Lean , you can request a refund by sending an email to the address given inside the product and we will immediately refund your entire purchase price, with no questions asked. Or click “Continue Reading” to return to the letter. Claim your free PentagonFit Fitness Tracker now!

Production 52

Production Containment Medicine Vaccination 52

pharmaphorum

FEBRUARY 26, 2021

Johnson’s Baby Powder also went on sale during this year and was extremely successful. Following World War II, Ethicon’s market share in surgical sutures rose from 15% to 70% worldwide. Johnson & Johnson was founded over 125 years ago in the year 1886. Where it all began.

Sales 126

Sales Production Pharma Companies Marketing 126

pharmaphorum

JUNE 15, 2021

The adoption of New Science – a unique combination of the best in science and health technology that address significant unmet patient needs – is delivering more precise and effective treatments, but often at a higher price tag, according to new research. New Science is more important than ever. New Science is clearly on the rise.

Clinical Trials 90

Clinical Trials Clinical Trials Development Marketing 90

Pharmaceutical Technology

NOVEMBER 30, 2022

Over the past few years, there has been a boom in anti-obesity drug development, with major companies achieving substantial sales in the field. According to GlobalData, as of November 28, there were 316 generic and novel drugs marketed to treat obesity. The UK and US are both undergoing an obesity crisis. were overweight but not obese.

Drugs 264

Drugs Manufacturing Hormones Contract Manufacturing 264

Pharmaceutical Technology

NOVEMBER 30, 2022

Over the past few years, there has been a boom in anti-obesity drug development, with major companies achieving substantial sales in the field. According to GlobalData, as of November 28, there were 316 generic and novel drugs marketed to treat obesity. The UK and US are both undergoing an obesity crisis. were overweight but not obese.

Drugs 246

Drugs Manufacturing Hormones Contract Manufacturing 246

World of DTC Marketing

JUNE 16, 2021

The pharma industry has been riding a wave of public approval since they developed a vaccine to fight COVID-19, but that goodwill is going to be short lived thanks, in part, to the $56,000 price tag of Biogen’s new drug and insulin that too many people still can’t afford. But changes are coming; it’s only a matter of time.

Drugs 180

Drugs Branding Medicine Insulin 180

Pharma Marketing Network

JUNE 8, 2020

This is Don Langsdorf with the Pharma Marketing Network pleased to welcome today Dave Chase, co-founder of the Health Rosetta. Don (PMN): Hi welcome. Good morning, Dave. Thanks for coming on the podcast and if you wouldn’t mind, could tell us a little bit about yourself. Dave (HR): Sure. Thanks for having me on.

HR 40

HR Marketing Doctors Doctor 40